Compare Dell Technologies Inc (DELL) vs Definium Therapeutics Inc. Common Shares (DFTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dell Technologies Inc vs Definium Therapeutics Inc. Common Shares — how do they compare? Dell Technologies Inc trades at $581.88 (market cap $368.11B), while Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B). The key difference: Dell Technologies Inc is far larger — about 78.2× Definium Therapeutics Inc. Common Shares's market cap, and Dell Technologies Inc pays a 0.44% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dell Technologies Inc for 57 Days and Definium Therapeutics Inc. Common Shares for 0 Days on average.
| DELL | DFTX | |
|---|---|---|
Market Cap | $368.11B | $4.71B |
Volume | 3,975,387 | 1,966,636 |
Sector | Technology | Health |
52-Week High | $588.67 | $48.45 |
52-Week Low | $111.10 | $10.68 |
Typical Hold Time | 57 Days | 0 Days |
Enterprise Value | $391.01B | $3.67B |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dell Technologies (DELL) trades at $574.74, up 0.16% today, with a bullish technical outlook from moving averages and a consensus analyst price target of $566.35. The stock is buoyed by strong AI server demand, with Q2 2026 EPS of $7.04 beating estimates by 43% and revenue guidance for fiscal 2027 raised to approximately $192 billion. Recent news highlights a 20% dividend increase and a $74 billion AI server backlog, though the RSI suggests mild overbought conditions near resistance at $584.
The outlook for Dell is positive, driven by explosive growth in AI infrastructure orders and robust financial performance. Key opportunities include expanding profit margins and capital returns, while risks involve execution on the large backlog, competitive pressures in the server market, and reliance on continued AI investment trends. The stock's valuation at a P/E of 33.68 reflects high growth expectations.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dell Technologies Inc
VMware is an industry titan in virtualizing IT infrastructure and became a stand-alone entity after spinning off from Dell Technologies in November 2021. The software provider operates in the three segments: licenses
Read more on DELL →About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →
